Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Clinical trial NCT06577987 · RECRUITING

Trial details

NCT number: NCT06577987
Sponsor: Circle Pharma
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Refractory Solid Tumor Cancer Lung Cancer Triple Negative Breast Cancer Breast Neoplasms Neuroendocrine Tumors Neuroendocrine Carcinoma RB1 Gene Mutation

Start date: 2024-08-14
Primary completion: 2027-01-14
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.